Accelerates Commercial Focus With Multiple Registration Targets, Including Vaccine Enhancement PHILADELPHIA, Sept. 3, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that the Company will present at the BioPharm America Conference to be held on September 9 to 10, 2008 at the Grand Hyatt, Atlanta, GA. The oral presentation, "TLRs: New Targets for Broad-Based Pharmaceutical...
[read full story]